Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2005 1
2006 2
2007 1
2008 2
2009 2
2010 3
2011 4
2012 1
2015 2
2019 1
2020 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Imatinib mesylate for the treatment of pulmonary arterial hypertension.
ten Freyhaus H, Dumitrescu D, Berghausen E, Vantler M, Caglayan E, Rosenkranz S. ten Freyhaus H, et al. Among authors: vantler m. Expert Opin Investig Drugs. 2012 Jan;21(1):119-34. doi: 10.1517/13543784.2012.632408. Epub 2011 Nov 11. Expert Opin Investig Drugs. 2012. PMID: 22074410 Review.
Disrupted PI3K subunit p110α signaling protects against pulmonary hypertension and reverses established disease in rodents.
Berghausen EM, Janssen W, Vantler M, Gnatzy-Feik LL, Krause M, Behringer A, Joseph C, Zierden M, Freyhaus HT, Klinke A, Baldus S, Alcazar MA, Savai R, Pullamsetti SS, Wong DW, Boor P, Zhao JJ, Schermuly RT, Rosenkranz S. Berghausen EM, et al. Among authors: vantler m. J Clin Invest. 2021 Oct 1;131(19):e136939. doi: 10.1172/JCI136939. J Clin Invest. 2021. PMID: 34596056 Free PMC article.
Stamp2 Protects From Maladaptive Structural Remodeling and Systolic Dysfunction in Post-Ischemic Hearts by Attenuating Neutrophil Activation.
Mollenhauer M, Bokredenghel S, Geißen S, Klinke A, Morstadt T, Torun M, Strauch S, Schumacher W, Maass M, Konradi J, Peters VBM, Berghausen E, Vantler M, Rosenkranz S, Mehrkens D, Braumann S, Nettersheim F, Hof A, Simsekyilmaz S, Winkels H, Rudolph V, Baldus S, Adam M, Freyhaus HT. Mollenhauer M, et al. Among authors: vantler m. Front Immunol. 2021 Oct 6;12:701721. doi: 10.3389/fimmu.2021.701721. eCollection 2021. Front Immunol. 2021. PMID: 34691017 Free PMC article.
Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling.
Vantler M, Jesus J, Leppänen O, Scherner M, Berghausen EM, Mustafov L, Chen X, Kramer T, Zierden M, Gerhardt M, Ten Freyhaus H, Blaschke F, Sterner-Kock A, Baldus S, Zhao JJ, Rosenkranz S. Vantler M, et al. Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1434-44. doi: 10.1161/ATVBAHA.114.304887. Epub 2015 Apr 23. Arterioscler Thromb Vasc Biol. 2015. PMID: 25908763
Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension.
Ten Freyhaus H, Berghausen EM, Janssen W, Leuchs M, Zierden M, Murmann K, Klinke A, Vantler M, Caglayan E, Kramer T, Baldus S, Schermuly RT, Tallquist MD, Rosenkranz S. Ten Freyhaus H, et al. Among authors: vantler m. Arterioscler Thromb Vasc Biol. 2015 May;35(5):1236-45. doi: 10.1161/ATVBAHA.114.304864. Epub 2015 Mar 5. Arterioscler Thromb Vasc Biol. 2015. PMID: 25745058 Free PMC article.
Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases.
ten Freyhaus H, Dagnell M, Leuchs M, Vantler M, Berghausen EM, Caglayan E, Weissmann N, Dahal BK, Schermuly RT, Ostman A, Kappert K, Rosenkranz S. ten Freyhaus H, et al. Among authors: vantler m. Am J Respir Crit Care Med. 2011 Apr 15;183(8):1092-102. doi: 10.1164/rccm.200911-1663OC. Epub 2010 Dec 22. Am J Respir Crit Care Med. 2011. PMID: 21177885
21 results